Revenue
2018
2019
2020
2021
2022
2023
2024
2025
CUMBERLAND PHARMACEUTICALS INC (CPIX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.5M | $37.9M | $39.6M | $42.0M | $35.0M | $35.8M | $32.4M | $28.8M | $40.4M | $32.5M | $900,000 | $600,000 | $800,000 | $700,000 | $51.1M | $45.9M | $43.5M |
| Research & development | $5.6M | $4.8M | $5.8M | $6.7M | $5.7M | $5.8M | $6.9M | $7.6M | $4.3M | $3.2M | $3.8M | $3.4M | $5.6M | $5.1M | $5.0M | $4.3M | $5.0M |
| Operating income | −$2.8M | −$6.4M | −$9.6M | −$5.7M | −$7.7M | −$6.4M | −$9.3M | −$11.2M | −$4.1M | −$1.4M | $1.1M | $3.6M | −$3.8M | $8.8M | $9.8M | $6.5M | $5.8M |
| EBITDAderived | $1.4M | −$1.5M | −$4.6M | −$376,816 | −$3.1M | −$1.6M | −$4.9M | −$8.2M | −$1.4M | $963,777 | $3.4M | $5.5M | −$2.5M | $9.7M | $10.9M | $7.5M | $6.6M |
| Net income | −$2.8M | −$6.5M | −$6.3M | −$5.6M | −$3.5M | −$3.3M | −$3.5M | −$7.0M | −$8.0M | −$944,683 | $731,351 | $2.4M | −$2.1M | $5.8M | $5.7M | $2.5M | $3.1M |
| Basic EPSper diluted share | -$0.19 | -$0.46 | -$0.44 | -$0.38 | -$0.24 | -$0.22 | -$0.23 | -$0.45 | -$0.50 | -$0.06 | $0.04 | $0.14 | -$0.11 | $0.30 | $0.28 | $0.12 | $0.22 |
| Diluted EPSper diluted share | -$0.19 | -$0.46 | -$0.44 | -$0.38 | -$0.24 | -$0.22 | -$0.23 | -$0.45 | -$0.50 | -$0.06 | $0.04 | $0.14 | -$0.11 | $0.30 | $0.28 | $0.12 | $0.17 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 29, 2025Form 4 · 10b5-1 | Young CarolineDirector | BuyCommon Stock | 6 | $3.45 | $20.70 | 32.9K |
| Aug 29, 2025Form 4 · 10b5-1 | Jones JamesDirector | BuyCommon Stock | 13 | $3.45 | $44.85 | 43.9K |
| Aug 29, 2025Form 4 · 10b5-1 | KAZIMI A JChairman and CEO | BuyCommon Stock | 13 | $3.45 | $44.85 | 5.70M |
| Aug 29, 2025Form 4 · 10b5-1 | Krogulski KennethDirector | BuyCommon Stock | 68 | $3.45 | $234.60 | 289.7K |
| Aug 28, 2025Form 4 · 10b5-1 | Young CarolineDirector | BuyCommon Stock | 6 | $3.47 | $20.82 | 32.9K |